Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-25T01:38:37.693Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers

Published online by Cambridge University Press:  15 May 2009

A. E. J. Evans ,
R. L. L. Simmons ,
R. D. Ferris ,
S. K. Hasell ,
E. Letley  and
D. S. Freestone
A. E. J. Evans
Affiliation:
Works Medical Officer, ICI Organics Division, Manchester
R. L. L. Simmons
Affiliation:
Departments of Clinical Immunology and Viral Products Quality Control, The Wellcome Research Laboratories, Beckenham, Kent
R. D. Ferris
Affiliation:
Departments of Clinical Immunology and Viral Products Quality Control, The Wellcome Research Laboratories, Beckenham, Kent
S. K. Hasell
Affiliation:
Departments of Clinical Immunology and Viral Products Quality Control, The Wellcome Research Laboratories, Beckenham, Kent
E. Letley
Affiliation:
Departments of Clinical Immunology and Viral Products Quality Control, The Wellcome Research Laboratories, Beckenham, Kent
D. S. Freestone
Affiliation:
Departments of Clinical Immunology and Viral Products Quality Control, The Wellcome Research Laboratories, Beckenham, Kent
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Intranasal vaccination with a single 0·5 ml dose of 107.0 EID 50 WRL 105 strain live influenza vaccine elicited four-fold or greater increases in circulating homotypic haemagglutinating inhibiting (HAT) antibody in 60 (64·5 %) of 93 volunteers, or in 58 (74·4%) of 78 volunteers with HAI antibody titres before vaccination of ≤ 1/20. In comparison, in a group of volunteers vaccinated 9 months previously re-vaccination elicited antibody responses in only 4 (6·9 %) of 58 volunteers, or in 3 (14·3%) of 21 volunteers with antibody titres before vaccination of ≤ 1/20.

Titres of vaccine-induced antibody and antibody resulting from earlier natural infection appeared to fall slowly and at equivalent rates over a 9 month period.

Type
Research Article
Information
Journal of Hygiene , Volume 82 , Issue 3 , June 1979 , pp. 489 - 495
Copyright
Copyright © Cambridge University Press 1979

References

REFERENCES

Evans, A. E. J., Letley, E., Ferris, R. D. & Freestone, D. S. (1976). WRL 105 strain live attenuated influenza vaccine: comparison of one and two dose schedules. Journal of Hygiene 77, 327–32.CrossRefGoogle ScholarPubMed
Fenton, R. J., Jennings, R. & Potter, C. W. (1977). Differential response of ferrets to infection with virulent and avirulent influenza viruses: a possible marker of virus attenuation. Archives of Virology 55, 55–66.CrossRefGoogle ScholarPubMed
Freestone, D. S., Hamilton-Smith, S., Schild, G. C., Buckland, R., Chinn, S. & Tyrrell, D. A. J. (1972). Antibody responses and resistance to challenge in volunteers vaccinated with live (H3N2) influenza vaccines. Journal of Hygiene 70, 531–42.CrossRefGoogle ScholarPubMed
Freestone, D. S., Bowker, C. H., Letley, E., Ferris, R. D., White, W. G. & Barnes, G. M. (1976). A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination. Journal of Hygiene 76, 459–66.CrossRefGoogle ScholarPubMed
Freestone, D. S. (1976). Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers. Developments in Biological Standardization 33, 207–12.Google ScholarPubMed
Hobson, D., Beare, A. S. & Ward-Gardner, A. (1972). Haemagglutination-inhibiting serum antibody titres as an index of response of volunteers to intranasal infection with live, attenuated strains of influenza virus. Proceedings of the Symposium on Live Influenza Vaccines,Zagreb1971. Pp. 73–84. Yugoslav Academy of Sciences and Arts.Google Scholar
Meiklejohn, G., Kempe, C. H., Tahalman, W. G. & Lennette, E. H. (1952). Evaluation of monovalent influenza vaccines. Observations during an influenza A-prime epidemic. American Journal of Hygiene 55, 12–21.Google ScholarPubMed
Moffatt, M. A. J., Stealey, V. M., Freestone, D. S. & Macdonald, A. (1976). Assessment of elicited antibody responses, clinical reactions and transmissibility of WRL 105 live influenza vaccine. Journal of Biological Standardization 4, 91–5.CrossRefGoogle Scholar
Morris, C. A., Freestone, D. S., Stealey, V. M. & Oliver, P. R. (1975). Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity and transmissibility. Lancet ii, 196–9.CrossRefGoogle Scholar
Mostow, S. R. & Tyrrell, D. A. J. (1972). Detection of attenuation of recombinant influenza viruses in vitro. Lancet ii, 116–17.CrossRefGoogle Scholar
Sever, J. L. (1962). Application of a microtechnique to viral serological investigations. Journal of Immunology 88, 320–9.CrossRefGoogle ScholarPubMed
Stealey, V. M., McCahon, D. & Freestone, D. S. (1976). Preparation and characterisation of live recombinant influenza vaccine. Developments in Biological Standardization 33, 191–6.Google ScholarPubMed
Takatzy, G. (1955). The use of spiral loops in serological and virological micro-methods. Acta microbiologica Academiciae scientarum hungaricae 3, 191–202.Google Scholar